来自Coptis chinensis的多糖类的抗过敏活性
Dangyue Yin1, Xinyuan Cao2, Shanshan Li3
1College of Forestry, Northwest A&F University, Yangling 712100, Shaanxi, China; School of Astronautics, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China.
International journal of biological macromolecules
|May 27, 2025
概括
科普蒂斯中国的多糖有效地减少了小鼠的过敏反应,通过改善肠道微生物群和降低关键的过敏标志物. 这凸显了它们在开发新的食物过敏疗法方面的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 科普蒂斯 (Coptis chinensis) 是一种传统的中国草药,具有已知的抗过敏性质.
- 多糖是具有潜在治疗应用的生物活性化合物.
研究的目的:
- 为了研究Coptis chinensis多糖的抗过敏作用和机制.
- 评估纯化同聚糖对过敏反应和肠道微生物群的影响.
主要方法:
- 提取和净化Coptis chinensis的多糖类 (CP1和CP2-3-1). 提取和净化Coptis chinensis的多糖类 (CP1和CP2-3-1).
- 对多糖化合物的组成,分子量和功能群的分析.
- 对卵素 (OVA) 敏感小鼠的抗过敏作用的评估,包括症状评分,血清学分析 (IgE,mMcep1,IL-4) 和肠道微生物群概况.
主要成果:
- 纯化同型多糖 (CP2-3-1) 与原始多糖 (CP1) 相比,显示出更高的抗过敏功效.
- CP2-3-1治疗显著改善了过敏症状,减少了炎症标志物,并恢复了膜结构.
- CP2-3-1调节了肠道微生物群的组成,增加了丰富性和多样性,并恢复了关键的细菌种群.
结论:
- 科普蒂斯尼斯 (Coptis chinensis) 的同聚糖具有显著的抗过敏特性.
- 治疗效果与免疫反应和肠道微生物群的调节有关.
- 中华的同聚糖体显示出作为一种新的治疗食物过敏的有希望的药物.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
246
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
901
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
901
Cholinergic Antagonists: Pharmacokinetics
423
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
423
Allergic Reactions
27.3K
Overview
27.3K
Cross-reactivity
31.0K
Overview
31.0K


